Skip to main content

Table 5 Univariate models of cost and medical personnel utilization per patient in the total cohort (n = 218)

From: The cost of antiretroviral therapy in Haiti

Treatment cost Relative difference 95% CI p-value
Survived during observation period (n = 183) 2.11 (1.71, 2.61) <0.0001
Hospitalized during ART (n = 20) 1.50 (1.13, 2.01) 0.0052
ART changed due to side effects (n = 27) 1.40 (1.09, 1.79) 0.0083
Weight above lowest quartile at baseline (n = 155) 1.25 (1.03, 1.52) 0.0244
Fewer than 5 symptoms at ART initiation (n = 147) 1.22 (1.03, 1.46) 0.0238
Physician time Relative difference 95% CI p-value
ART changed due to side effects or failure (n = 27) 1.62 (1.34, 1.97) <0.0001
Survived during observation period (n = 183) 1.59 (2.18, 3.78) <0.0001
Treated for TB (n = 33) 1.58 (1.32, 1.88) <0.0001
Female gender (n = 122) 1.22 (1.07, 1.39) 0.0040
No Income (n = 125) 1.20 (1.05, 1.37) 0.0089
Nurse time Relative difference 95% CI p-value
Treated for TB (n = 33) 1.56 (1.27, 1.90) <0.0001
Survived during observation period (n = 183) 2.13 (1.68, 2.70) <0.0001